Atlas Trials

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

Clinical trial NCT05181605 · UNKNOWN

Trial details

NCT number
NCT05181605
Sponsor
Instituto de investigación e innovación biomédica de Cádiz
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Pancreatic AdenocarcinomaPancreatic Cancer Resectable
Start date
2022-04-15
Primary completion
2023-04-15
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.